Author
Over 318,000 health apps are available in app stores, but only a fraction are regulated by the U.S. Food and Drug Administration.
How can we mitigate biases in AI-based health care? And how can we ensure that AI improves health care, rather than augmenting existing disparities?
Who owns the data that are collected via direct-to-consumer health apps? Who should own that data?
Should consumers have access to the data that are collected via direct-to-consumer health apps? What real-world challenges might this create?
Direct-to-consumer health apps provide a window into key issues in the world of digital health. In this post, respondents consider data privacy concerns.
Testing, quarantine and contact tracing were employed to detect and prevent further transmission of the virus. Breach of orders was criminally punishable.
This post originally appeared in Device and Materials Engineering. You can read it here. By Sara Gerke and I. Glenn Cohen In our new paper, we discuss the ethical challenges of ingestible electronics sensors (IESs;…
A recent US lawsuit highlights crucial challenges at the interface of data utility, patient privacy & data misuse By Timo Minssen (CeBIL, UCPH), Sara Gerke & Carmel Shachar Earlier, we discussed the new suit filed…
By Timo Minssen (CeBIL, UCPH), Sara Gerke & Carmel Shachar A recent US lawsuit highlights crucial challenges at the interface of data utility, patient privacy & data misuse The huge prospects of artificial intelligence and machine…
A new working paper from participants in the AI-Health Working Group sets forth a research agenda for stakeholders to proactively collaborate and design AI technologies that work with users to improve their health and wellbeing.
